Platform can help predict a woman's five-year risk for developing breast cancer by analyzing routine mammograms ...

FDA staffers in the Center for Devices and Radiological Health told NBC News that their AI pilot, CDRH-GPT, is buggy, isn't ...

The U.S. FDA announced this week that it deployed a generative AI tool called ELSA, now in use by staff across the agency, ...

Dubbed Elsa, the tool was expected to roll out at the end of June. The FDA says it marks the dawn of a new era.

Finally, sources told WSJ that Witty didn't have a background in the U.S. insurance industry; he was formerly the CEO of ...

AI-driven Clairity Breast platform, now FDA-approved, predicts five-year breast cancer risk from mammograms, enhancing early ...

The U.S. Food and Drug Administration said on Monday that it had launched a generative AI tool, Elsa, aimed at improving ...

Alex Ratner, CEO of Snorkel AI, remembers a time when data labeling —the grueling task of adding context to swathes of raw ...

There are problems with generative AI, and there need to be guardrails and there needs to be human oversight," said Jason ...

The agency has provided only limited details about its AI pilot as it advances an “aggressive timeline” for the tool's ...

FDA employees report the agency's new AI assistant produces incorrect answers and lacks essential safeguards. (Shutterstock) ...

FDA announced the launch of Elsa, a generative AI tool designed to “help employees—from scientific reviewers to ...